Does smoking reefer lead to using other drugs, in daily practice usually described as cocaine and heroin? Raising the possibility that the answer to this question might be affirmative, is known as the stepping stone hypothesis. Recently this hypothesis has been raised again in slightly other terms: cannabis use as a “gateway” to other allegedly more dangerous drugs.
Janet E. Joy, Stanley J. Watson, Jun Borras, Sebastian Scholl , John A. Benson, Wendy Wolford
01 January 1999
The medical use of marijuana is surrounded by a cloud of social, political, and religious controversy, which obscures the facts that should be considered in the debate. This book summarizes what we know about marijuana from evidence-based medicine--the harm it may do and the relief it may bring to patients. The book helps the reader understand not only what science has to say about medical marijuana but also the logic behind the scientific conclusions.
Eliseu Labigalini Jr, Lucio Ribeiro Rodrigues, Dartiu Xavier Da Silveira
01 October 1999
This study ensued from clinical observations based on spontaneous accounts by crack abusers undergoing their first psychiatric assessment, where they reported using cannabis in an attempt to ease their own withdrawal symptoms.
Martin Jelsma is a political scientist who has specialised in Latin America and international drugs policy. In 2005, he received the Alfred R. Lindesmith Award for Achievement in the Field of Scholarship, which stated that Jelsma "is increasingly recognized as one of, if not the, outstanding strategists in terms of how international institutions deal with drugs and drug policy."...
Tom Blickman is a Senior Project Officer at the Transnational Institute (TNI), based in Amsterdam. Since 1997, he has been working for TNI's Drugs & Democracy Programme, specializing in international drug control policy and the UN conventions, drug markets, alternative development, money laundering and organised crime. Tom is a regular speaker at international policy conferences and advises...
Ernestien Jensema (1971) is a social anthropologist who has been working as a researcher and project coordinator with the Drugs & Democracy Programme of TNI since 2008. She focuses on issues related to the UN drug control system and the Drugs and Democracy Programme’s Asia project....
U.S. drug control officials have denounced Dutch drug policy as if it were the devil himself. One former U.S. Drug Czar said "you can't walk down the street in Amsterdam without tripping over junkies." In the Summer of 1998, however, one such denouncement turned into a small scandal. The first part of this chapter examines this incident as a window on the politics of drug policy. The second part offers a more general analysis of why U.S. drug control officials seem to be so threatened by the Dutch example.
The present paper focuses on the pros & cons of the main dichotomy in the field of drug control policy: that between criminalization and decriminalization. In the extensive opening chapter dedicated to the “Premises”, the various points of view about the advisability of having recourse to criminal sanctions are examined.
Cannabis is the cutting-edge drug for reform, the only politically plausible candidate for major legal change, at least decriminalisation (removal of criminal penalties for possession) and perhaps even outright legalisation (permitting production and sale). Compared with other drugs, the harms, physiological or behavioural, are less severe and the drug is better integrated into the culture. Throughout Western Europe and in the Antipodes there is pressure for reductions in the punitiveness of the marijuana regime.
An ethnographic study of women and drug use in inner city neighborhoods in Kingston, Jamaica, revealed that cannabis is commonly used in conjunction with crack cocaine to minimize the undesirable effects of crack pipe smoking, specifically paranoia and weight loss.
A strong attack against the European practice of 'leniency' regarding cannabis use and possession took place at the United Nations Commission on Narcotic Drugs (CND) session (11-15 March, 2002) in Vienna. There was an orchestrated attempt to pass a CND resolution to put a dam against the 'leniency'.
Cannabis like other illicit drugs is so-called ‘controlled drug’. A closer look makes clear that these drugs are in fact far from being ‘controlled’. The cultivation, trade, transport, wholesale distribution, sale, and above all the unsafe composition, potency and quality of the products are not controlled at all. Neither is the use. All this is a threat to public health. Fortunately, there is an alternative at hand.
Mirjam van het Loo, Stijn Hoorens, Christian van ‘t Hof, James P. Kahan
01 June 2003
This report examines what is known about the effects of policies regarding the possession and use of cannabis. Such policies continue to be subject to debate in most if not all European countries. Different governments have made different policy decisions, varying from explicit toleration (but not full legalisation) to strict prohibition. Policymaking would be served by insight in the relationship between different cannabis policies and their outcomes, such as prevalence of cannabis use and social consequences for cannabis users and for society as a whole.
Craig Reinarman, Peter Cohen, Sebastian Scholl , Hendrien L. Kaal
01 May 2004
Decriminalizing cannabis doesn't lead to more widespread use, according to a study comparing cannabis users in two similar cities with opposing cannabis policies — Amsterdam, the Netherlands (decriminalization), and San Francisco, California (criminalization). The study compared age at onset, regular and maximum use, frequency and quantity of use over time, intensity and duration of intoxication, career use patterns, and other drug use. No evidence was found to support claims that criminalization reduces use or that decriminalization increases use.
Windows of opportunity for changing drug laws open infrequently and they often close without legislative change being affected. In this paper the author, who has been intimately involved in the process, describes how evidence-based recommendations to ‘decriminalize’ cannabis have recently been progressed through public debate and the political process to become law in Western Australia (WA). This paper describes some of the background to the scheme, the process by which it has become law, the main provisions of the scheme and its evaluation. It includes reflections on the role of politics and the press in the process.
This paper provides a framework for understanding what decriminalization means within the broader context of depenalization. To illustrate these concepts, it provides a detailed discussion of a range of depenalization policies observed in developed countries, highlighting for each country a distinct issue that influences how the policy is implemented and its potential impact.
This study examines the current knowledge of physiological and clinical effects of tetrahydrocannabinol (THC) and cannabidiol (CBD) and presents a rationale for their combination in pharmaceutical preparations. Cannabinoid and vanilloid receptor effects as well as non-receptor mechanisms are explored, such as the capability of THC and CBD to act as anti-inflammatory substances independent of cyclo-oxygenase (COX) inhibition. CBD is demonstrated to antagonise some undesirable effects of THC including intoxication, sedation and tachycardia, while contributing analgesic, anti-emetic, and anti-carcinogenic properties in its own right.
Het Nederlandse cannabisbeleid verkeert al decennia in een internationaalrechtelijke schemerzone, stelt Martin Jelsma van het Transnational Institute (TNI). Nederland gedoogt de verkoop van kleine hoeveelheden softdrugs in coffeeshops (de zogenaamde voordeur), maar de aanvoer ervan (de achterdeur) is tot dusver verboden. In de loop der jaren is hierdoor een omvangrijke illegale sector ontstaan in Nederland die de coffeeshops bevoorraadt met nederwiet. Een kamermeerderheid wil nu het gedoogbeleid uitbreiden door een experiment met een gereguleerde aanvoer van wiet aan de achterdeur van coffeeshops, maar het kabinet is tegen.
The largest study of its kind has unexpectedly concluded that smoking marijuana, even regularly and heavily, does not lead to lung cancer. The new findings "were against our expectations," said Donald Tashkin of the University of California at Los Angeles, a pulmonologist who has studied marijuana for 30 years. Marijuana also contains the chemical THC, which he said may kill aging cells and keep them from becoming cancerous.